ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Istituto Oncologico Veneto (IOV) at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Istituto Oncologico Veneto (IOV) takes part in 10 sessions at ESMO 2026 in Madrid. Its work spans cancers of the lung, breast, bowel, kidney and skin, among other areas. Specific topics include treatment outcomes in metastatic colorectal cancer, melanoma and pleural mesothelioma.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Public cancer research hospital of the Veneto region in Padua, Italy.
Poster
Fri Oct 23
13:00–15:00
Early treatment failure with immune checkpoint inhibitors in R/M HNSCC: Clinical predictors from a real-world cohort
ePoster session 8
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Pembrolizumab-based first-line treatment in recurrent/metastatic HNSCC: A real-world analysis of clinical selection
ePoster session 8
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
15:15–16:00
Abstract
Sat Oct 24
15:42–15:47
Poster
Sun Oct 25
12:00–12:45
Poster
Mon Oct 26
12:00–12:45
Surgical outcomes in pleural mesothelioma (PM) patients receiving neoadjuvant chemoimmunotherapy (CT-IO): Results from the phase II CHIMERA study
Monday Poster Display session 4
Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Istituto Oncologico Veneto (IOV)

Tell us what you sell and we’ll find the people at Istituto Oncologico Veneto (IOV) most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction